A Critical Analysis and Discussion of the Appropriateness of the Schizophrenia Consensus Remission Criteria in Clinical Pharmaceutical Trials-Reference-Cited by-同舟云学术

A Critical Analysis and Discussion of the Appropriateness of the Schizophrenia Consensus Remission Criteria in Clinical Pharmaceutical Trials

Published:2010-10-06 Issue:07 Volume:43 Page:245-251
ISSN:0176-3679
Container-title:Pharmacopsychiatry
language:en
Short-container-title:Pharmacopsychiatry

Author:

Schennach-Wolff R.,Möller H.-J.,Jäger M.,Seemüller F.,Obermeier M.,Messer T.,Laux G.,Pfeiffer H.,Naber D.,Schmidt L. G.,Gaebel W.,Klosterkötter J.,Heuser I.,Maier W.,Lemke M. R.,Rüther E.,Klingberg S.,Gastpar M.,Riedel M.

Publisher

Georg Thieme Verlag KG

Subject

Pharmacology (medical),Psychiatry and Mental health,General Medicine

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0030-1262788.pdf

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Successful administration of cariprazine in a young, severely ill patient with recurrent relapses of schizophrenia and persistent negative symptoms;Frontiers in Psychiatry;2023-03-09

2. What happens with schizophrenia patients after their discharge from hospital? Results on outcome and treatment from a “real-world” 2-year follow-up trial;European Archives of Psychiatry and Clinical Neuroscience;2019-08-28

3. Remission in schizophrenia — What are we measuring? Comparing the consensus remission criteria to a CGI-based definition of remission and to remission in major depression;Schizophrenia Research;2019-07

4. Schizophrene Psychosen;Psychiatrie, Psychosomatik, Psychotherapie;2017

5. Validity of remission and recovery criteria for schizophrenia and major depression: comparison of the results of two one-year follow-up naturalistic studies;European Archives of Psychiatry and Clinical Neuroscience;2016-10-26